Figure 5

Kaplan–Meier survival curve of intention to treat population illustrates cumulative incidence of ovulation inhibition of delayed-starting on day 7–9. EE/GS ethinyl estradiol 0.02 mg plus gestodene 0.075 mg, DRSP 4 mg drospirenone.

Kaplan–Meier survival curve of intention to treat population illustrates cumulative incidence of ovulation inhibition of delayed-starting on day 7–9. EE/GS ethinyl estradiol 0.02 mg plus gestodene 0.075 mg, DRSP 4 mg drospirenone.